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Objectives: We aimed to explore physiological responses to the six-minute walk test (6MWT)
and assess computed tomographic (CT) features of the lungs and thigh muscle in order to
determine contributors to dyspnea intensity and exercise limitation in dyspneic and non-
dyspneic subjects with GOLD-1 COPD and controls.
Methods: We compared Borg dyspnea ratings, ventilatory responses to 6MWT, and CT-measures
of emphysema, airway lumen caliber, and cross-sectional area of the thigh muscle (RTMCT-CSA)
in 19 dyspneic, 22 non-dyspneic, and 30 control subjects.
Results: Dyspneic subjects walked less and experienced greater exertional breathlessness than
non-dyspneic (105 m less and 2.4 Borg points more, respectively) and control subjects (94 m
less and 2.6 Borg points more, respectively (P < 005 for all comparisons). At rest, dyspneic
subjects had significant greater expiratory airflow obstruction, air trapping, ventilation/perfu-
sion mismatch, burden of emphysema, narrower airway lumen, and lower RTMCT-CSA than
comparison subjects. During walking dyspneic subjects had a decreased inspiratory capacityof Pulmonary Diseases, Pontificia Universidad Cato´lica de Chile, Santiago, Chile.
. Dı´az).
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Dyspnea and exercise limitation in mild COPD 571(IC) along with high ventilatory demand. Dyspneic subjects exhibited higher end-exercise tidal
expiratory flow limitation and oxygen saturation drop than comparison subjects. In regression
analysis, dyspnea intensity was best explained by DIC and forced expiratory volume in 1 s %pre-
dicted. RTMCT-CSA and DIC were independent determinants of distance walked.
Conclusions: Among subjects with mild COPD, those with daily-life dyspnea have worse exer-
cise outcomes; distinct lung and thigh muscle morphologic features; and different pulmonary
physiologic characteristics at rest and exercise. DIC was the main contributor to dyspnea
intensity and DIC and thigh muscle wasting were determinants of exercise capacity.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Dyspnea is a cardinal symptom of chronic obstructive
pulmonary disease (COPD).1 It predicts survival,2 is part of
a mortality index for COPD,3 is used to select patients for
therapy,4 and was included in the new Global Initiative for
Obstructive Lung Disease (GOLD) classification scheme for
the disease.1 COPD subjects with dyspnea usually experi-
ence exercise limitation and often seek medical care.5 Low
exercise capacity is associated with poorer quality of life6
and low levels of daily physical activity are linked to
increased hospitalization rate and mortality.7 While deter-
minants of exertional dyspnea and exercise limitation have
long been recognized in COPD subjects with moderate-to-
severe airway obstruction,8e13 there is scarce data in
subjects with a milder disease.
Ofir et al.14 showed that symptomatic subjects withmild
COPD during cycling had reduced exercise capacity and
ventilatory abnormalities including dynamic hyperinflation
(DH) and that DH was linked to exertional dyspnea. DH has
also been observed during the six-minute walk test (6MWT)
and associated with exertional dyspnea in moderate-to-
severe COPD.9,15 Whether DH is associated with both
dyspnea and exercise performance during walking in
subjects with mild disease has not been determined.
Computed tomography (CT) is increasingly used to assess
lung emphysema and morphology of the airways and loco-
motor muscles. A high burden of emphysema on CT scan
predicts poor exercise capacity16 and quadriceps muscle
wasting is associated with lower physical activity in daily
life in subjects with a wide spectrum of COPD.17 Whether
these morphologic abnormalities of the lung and thigh
muscle are related to dyspnea intensity and exercise
impairment and their potential underlying mechanisms in
mild COPD remain to be explored. Understanding func-
tionestructure relationships within the lungs can help to
improve the understanding of dyspnea during exercise and
thus advance patient care.
We hypothesize that compared to smoker controls and
non-dyspneic subjects with mild COPD, daily-life dyspneic
subjects with mild COPD during self-paced exercise: 1)
develop dynamic hyperinflation and increase ventilatory
demand, which lead to greater dyspnea perception and
lower exercise performance and; 2) have higher burden of
emphysema, narrower airways lumen and greater thigh
muscle wasting on CT scans which are associated with
greater dyspnea intensity and lower exercise capacity.
In order to assess these hypotheses, we evaluated meta-
bolic, pulmonary, and cardiac responses to the 6MWT;determine contributors to exertional dyspnea and exercise
limitation; and relate these outcomes and its underlying
mechanisms with CT features of the lung and thighmuscles in
subjects with mild COPD and controls. Preliminary results of
this study have been presented in the form of an abstract.18
Methods
Details on inclusion/exclusion criteria and lung function,
exercise, and CT imaging assessment as well as calculations
for exercise parameters are on the Online Supplement.
Subject selection
Subjects are from a COPD longitudinal study, PELE (Proyecto
de Evaluacio´n Longitudinal de la Enfermedad Pulmonar
Obstructiva Cro´nica). Briefly, the goal of the PELE study was
to assess the clinical, physiological, and morphological
determinants of the decline in exercise capacity in smokers
with COPD. This report is a cross-sectional analysis including
all Global Initiative for Obstructive Lung Disease (GOLD)19 1
COPD subjects and smoker controls (NZ 30). COPD subjects
were further divided into two groups: dyspneic (definedwith
a modified Medical Research Council20 [mMRC] score1; [D-
COPD], NZ 19) and non-dyspneic (ND-COPD, NZ 22). The
study was approved by the institutional review board of the
Catholic University of Chile, University of Chile, and Brigham
and Women’s Hospital (protocol #2012P000302). Written
informed consent was obtained from all participants.
Study design
A 3-visit baseline assessment was performed within a week.
The first visit included demographic andmedical history data
collection with a structured questionnaire and two training
6MWTs.21 In the second visit, pulmonary function assessment
and two additional 6MWTs using portable equipment were
performed. The final visit included CT imaging evaluation.
Lung function assessment
Subjects underwent spirometric testing before and after
200 mg of albuterol as well as maximal voluntary ventilation
(MVV), single-breath diffusing lung capacity for carbon
monoxide (DLCO), and lung volumes following international
guidelines.22e24 Spirometric, DLCO, and lung volumes
measurements were standardized as percentages of pre-
dicted values by using prediction equations.25e27
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Subjects performed two additional 6MWTs with a portable
telemetric system.28e30 Oxygen consumption (V0O2), carbon
dioxide production (V0CO2), minute ventilation (V0E),
respiratory exchange ratio (RER; V0CO2/V0O2), end-tidal
carbon dioxide partial pressure ðPETCO2Þ, heart rate (HR),
arterial oxygen saturation (SpO2), O2 pulse (V
0O2/HR),
31
tidal volume (VT), inspiratory (TI) and expiratory time
(TE), mean tidal inspiratory (VT/TI) and expiratory (VT/TE)
flow, inspiratory capacity30 (IC), and Borg dyspnea ratings32
were measured. DIC from rest was used to reflect the
change in end-expiratory lung volume and therefore
dynamic hyperinflation. For each subject the greatest of
both distance walked was selected for subsequent analysis.
Tidal flow-volume loops
Both flow and volume were recorded during the 6MWTs with
a portable system. End-exercise tidal flow-volume curves
were made and situated within their respective maximal
flow-volume loops. The presence and degree of expiratory
flow limitation (EFL) was calculated as the percentage of
tidal volume (%VT) that overlaps the maximal flow-volume
envelope.33
CT imaging
A volumetric CT scan examination of the chest and the thigh
muscle was performed. Emphysema was defined as percent
of low attenuation areas less than 960 Hounsfield units (%
LAA-960HU).34 CT-based, single-slice airway measurements
were collected in the right upper lobe apical bronchus
(RB1) and right lower lobe posterior basal bronchus (RB10)
as previously described.16,35 The 5th airway generation
luminal area (Ai) of RB1 and RB10 is reported. CT cross-
sectional area (CSA) of the right thigh muscle (RTMCT-CSA)
was measured following a described method.36
Statistical analysis
Baseline variables were compared by ANOVA with adjust-
ment for multiple comparisons, KruskaleWallis, and chi
square tests according to the variable type and distribution.
Group responses at time points during walking were
compared via repeated ANOVA with TukeyeKramer
adjustment for multiple comparisons. The relationships of
Borg ratings and distance walked to physiologic/morpho-
logic variables were assessed via Spearman correlation.
Separate regression analyses for Borg rating at min 6 and
distance walked were performed. Since Borg rating was
highly skewed it was log transformed. Analysis was per-
formed with SAS 9.2 (Cary, NC).
Results
Table 1 shows subjects’ clinical, lung function, and CT data.
D-COPD subjectsweremore likely to be older and had greater
airflow obstruction, air trapping, and ventilation/perfusion
(V/Q) mismatch along with a lower PaO2 than ND-COPDsubjects or controls. D-COPD subjects had significantly
higher %LAA-960, smaller airway Ai, and lower RTMCT-CSA on
CT scans than subjects of comparison groups. After adjust-
ment for age and gender the differences in Ai and RTMCT-CSA
across groups persisted (Online Table 1). Among dyspneic
subjects, 13 were receiving short-acting or long-acting
bronchodilators and 9 inhaled corticosteroids. Comparison
subject groups were no receiving any respiratorymedication.
Exercise data
Exercise data is shown in Table 2. D-COPD subjects walked
less than ND-COPD subjects and controls (476  75 vs.
581  70 vs. 570  70 m, respectively). Also dyspneic
subjects reported higher Borg ratings than comparison
subjects from minute 2 and thereafter reporting 2.6 more
points at the end of the test (Fig. 1A). D-COPD subjects had
greater exertional dyspnea at any V0E and greater dyspnea/
V0E slopes than comparison subjects from min 2 to 6
(Fig. 1B). In dyspneic subjects, while the rise in V0O2 and
V0CO2 were significantly lower than comparison subjects at
min 4 and thereafter, ventilatory equivalents for O2 (V
0E/
V0O2) and CO2 (V0E/V0CO2) were higher than comparison
subjects (Fig. 2AeC). D-COPD subjects also had a significant
decline in SpO2 compared to other subject groups (Fig. 2D).
At the end of exercise subjects had a greater degree of tidal
EFL (73.8  16.1%) than ND-COPD (13.5  14.6%) and
control subjects (4.1  7.8%; for both comparisons
P < 0.05) (Fig. 3). IC% predicted decreased 11.4  6.6%
(260 mL) from rest to min 6 in D-COPD subjects compared
to an increase of 3.0  2.6% (80 mL) in ND-COPD subjects
and 3.8  5.2% (90 mL) in controls (for both IC% predicted
comparisons P < 0.05) (Fig. 4). There were no significant
differences in RER and PETCO2 between groups.
Determinants of dyspnea intensity and exercise
capacity
In the full cohort, greater Borg ratings at min 6 were associ-
ated with decreasing IC% predicted (rZ 0.54, P < 0.0001)
(Fig. 5) and greater degree of EFL (%VT) (rZ 0.53, P< 0.001).
While Borg dyspnea score also correlated with FEV1% pre-
dicted (r Z 0.35, P Z 0.003), RTMCT-CSA (r Z 0.32,
PZ 0.007), SpO2 at min 6 (rZ0.31, PZ 0.009), V0E/V0CO2
at min 6 (r Z 0.34; P Z 0.004), and V0E/V0O2 at min 6
(rZ 0.29; PZ 0.015), it was marginally correlated with V0E,
% MVV at min 6 (r Z 0.23; P Z 0.054). Stepwise regression
chose DIC and FEV1% predicted to best describe Borg ratings
(R2Z 0.36; Pmodel<0.0001). Similar results were observed
when EFL replaced DIC% predicted in themodel. EFL and DIC
% predicted were highly correlated each other and when we
included both in a model to explain dyspnea in exertion, only
DIC% predicted remained as independent predictor.
The highest correlates of distance walked were RTMCT-
CSA (r Z 0.62), DO2 pulse% predicted (r Z 0.58), DIC%
predicted (r Z 0.50), and EFL (%VT) (r Z 0.46)
(P < 0.0001 for all correlations) (Fig. 6). In a regression
model including the three highest correlates, age, FEV1%
predicted, gender, and BMI, all the variables remained as
independent determinants of distance walked. This model
explained 77% of the variance. When DIC% predicted is
Table 1 Anthropometric, clinical, lung function, and CT data in dyspneic and non-dyspneic subjects with mild COPD and
smoker controls at baseline.
Smoker control Non-dyspneic COPD Dyspneic COPD
N 30 22 19
Gender, M/F 13/17 11/11 8/11
Age, years 63  8 61  10 69  8a,b
Pack-years smoked 26  18 38  18 50  23a
Current smoking, yes/no 16/14 12/10 7/12
Time quitting smoking, years 18.9  10.4 14.2  9.9 18.3  11.3
BMI, kg/m2 28  4 26  4 27  3
Modified MRC score 0 0 1 (1e2)a,b
FEV1, L 2.7  0.6 2.7  0.8 2.1  0.5a,b
FEV1, % predicted 100 (96e111) 92 (84e109) 86 (83e95)
a
FVC, L 3.7  0.8 4.2  1 3.7  1.1
FVC, % predicted 113  16 120  13 119  15
FEV1/FVC, % 75 (72e111) 68 (62e69) 59 (54e66)
a,b
DLCO/VA , ml CO/min/mmHg/L 4.4  0.7 4.2  0.6 3.4  0.8a,b
DLCO/VA, % predicted 124  21 118  16 99  24a,b
PaO2, mmHg 83  7 82  7 73  8a,b
PaCO2, mmHg 39  2 37  3 38  3
TLC, L 5.5  1.0 6.4  1.4 6.0  1.5
TLC, % predicted 103  12 115  11 114  12a
RV, L 1.9  0.4 2.2  0.6 2.3  0.6a
RV, % predicted 90  16 107  23 106  19a
RV/TLC, % 34  5 35  6 39  8a
V0E, L/min 10  2.3 10.8  2.9 11.6  2.3
VT, L 0.60 (0.53e0.71) 0.73 (0.57e0.80) 0.70 (0.57e0.83)
VT, % predicted VC 19 (16e23) 21 (17e24) 22 (18e26)
F, breaths/min 15 (14e19) 15 (14e17) 18 (14e20)
IC, L 2.52  0.48 2.60  0.65 2.48  0.60
IC, % predicted 93  15 93  15 99  10
RTMCT-CSA, cm
2 75.5  17 78.4  18 57.6  16a,b
% LAA-960HU, % 4.0 (2.7e6.2) 5.3 (3.5e7.3) 9.1 (7.0e16.4)a,b
5th generation Ai of RB1, mm2 6.7  2.9 6.5  3.8 4.1  1.6a
5th generation Ai of RB10, mm2 12.4  8.2 8.2  4.6 6.4  2.4a
Values are expressed as frequency, mean  standard deviation or median (interquantile range).
Abbreviations: M, Male; F, Female; BMI, Body Mass Index; MRC, Medical Research Council; FEV1, Forced Expiratory Volume in 1 Second;
FEV1/FVC, Ratio of Forced Expiratory Volume in 1 s to Forced Vital Capacity; DLCO/VA, Ratio of Diffusing Lung Capacity for Carbon
Monoxide/Alveolar Volume; PaO2, Arterial Oxygen Tension; PaCO2, Arterial Carbon Dioxide Tension; TLC, Total Lung Capacity; RV,
Residual Volume; RV/TLC Ratio of Residual Volume to Total Lung Capacity; V0E, Minute Ventilation; VT, Tidal Volume; VC, Vital Capacity;
F, Respiratory Rate; IC, Inspiratory Capacity; RTMCT-CSA, Cross-sectional Area of the Right Thigh Muscle by Computed Tomography; %LAA-
960 HU, Percent of Low-attenuation Areas Less than 960 Hounsfield Units; Ai, Airway Luminal Area; RB1, Right Upper Lobe Apical
Bronchus; RB10, Right Lower Lobe Posterior Basal Bronchus.
a P < 0.05 vs. controls.
b P < 0.05 vs. Non-dyspneic COPD group.
Dyspnea and exercise limitation in mild COPD 573replaced by EFL (%VT) results were similar but gender is
marginally significant (PZ 0.054) and the model R2 is 0.73.
In a more parsimonious model that excluded age, gender,
and BMI, distance walked was best explained by the
combination of RTMCT-CSA, DIC% predicted, and DO2 pulse%
predicted (R2 Z 0.59). The same explanatory variables
remained when EFL (%VT) replaces DIC% predicted.Relationships between CT measures of emphysema,
airway narrowing, and physiologic variables
While %LAA-960 was not correlated with either Borg ratings
(r Z 0.19, P Z 0.1) or distance walked (r Z 0.13,
P Z 0.3), the 5th-airway generation Ai of the RB1 had aninverse relationship with dyspnea intensity (r Z 0.25,
P Z 0.03). Ai of both RB1 (r Z 0.32, P Z 0.007) and RB10
(r Z 0.34, P Z 0.003) had a direct relationship with exer-
cise performance. %LAA-960 was directly correlated with
the degree of EFL (%VT) (r Z 0.43, P Z 0.0002) and
inversely related to IC% predicted (rZ 0.39, PZ 0.0007).
Ai was associated with both EFL (RB1, rZ0.38, PZ 0.001;
RB10, r Z 0.47, P < 0.0001) and IC% predicted (RB1,
rZ 0.33, PZ 0.005; RB10, rZ 0.26, PZ 0.03).Discussion
In this study we examined physiological responses to 6MWT
and CT data in subjects with mild COPD and controls. We
Table 2 End-exercise metabolic, ventilatory and cardiovascular responses to the six-min walk test in dyspneic and non-
dyspneic subjects with mild COPD and smoker controls.
Smoker control Non-dyspneic COPD Dyspneic COPD
Distance walked, m 570  70 581  70 476  75a,b
Distance walked, % predicted 94  8 92  11 83  9a,b
Dyspnea, Borg units 1.3  1.0 1.5  1.2 3.9  2.3a,b
V0O2, L/min 1519  441 1487  426 1102  301a,b
V0O2, % predicted 109  21 101  21 86  21a,b
V0CO2, L/min 1414  442 1378  406 991  302a,b
V0O2, mL/kg/min 21  5 21  4 16  4a,b
RER 0.93  0.07 0.93  0.04 0.89  0.05
V0E, L/min 49  16 48  15 39  10a
V0E, % MVV 42  10 43  11 48  16
V0E/V0O2 32  4 32  4 36  6a,b
V0E/V0CO2 35  4 35  4 40  7a,b
DV0E/V0CO2 from rest, % 25  13 29  18 26  12
PETCO2 mm Hg 38.5  3.7 37.5  3.5 36.1  4.3
SpO2, % 96  2 96  2 91  7a,b
DSpO2 from rest, % 0.7  1.3 1.4  2.9 4.9  6.8a,b
EFL, % of VT overlapping
maximal flow-volume curve
4.1  7.8 13.5  14.6 73.8  16.1a,b
F, breaths/min 30  3 28  5 29  6
VT, L 1.63  0.4 1.73  0.5 1.41  0.5
VT, % predicted VC 50  9 50  9 45  9
DVT, % predicted VC from rest 162  59 154  84 107  55a
TI, s 0.73  0.13 0.80  0.16 0.77  0.21
TE, s 1.31  0.21 1.42  0.24 1.40  0.30
VT/TI, L/s 2.28  0.70 2.22  0.71 1.86  0.52
VT/TE, L/s 1.29  0.44 1.24  0.38 1.0  0.27a
IC, L 2.61  0.5 2.68  0.7 2.22  0.6a
IC, % predicted 96  14 96  16 88  14
DIC, % predicted from rest 3.8  5.2 3.0  2.6 11.4  6.6a,b
HR, beats/min 133  17 129  15 118  18a
HR, % predicted 85  11 82  10 77  11a
O2 pulse, ml/beat 11.4  3.0 11.5  3.0 9.5  2.9
O2 pulse, % predicted 109  19 104  23 94  21
DO2, % predicted from rest 248  84 235  86 170  78a,b
The values correspond to the min 6 or the change from rest to min 6 and are expressed as mean  standard deviation.
Abbreviations: V0O2, Oxygen Consumption; V0CO2, Carbon Dioxide Production; RER, Respiratory Exchange Ratio. V0E, Minute Ventilation;
MVV, Maximal Voluntary Ventilation; PETCO2 , End-tidal Carbon Dioxide Partial Pressure; SpO2, Arterial Oxygen Saturation by Pulse
Oximeter; EFL, Expiratory Flow-limitation; F, Respiratory Rate; VT, Tidal Volume; VC, Vital Capacity; TI, Tidal Inspiratory Time; TE, Tidal
Expiratory Time; VT/TI, Mean Tidal Inspiratory Flow; VT/TE, Mean Tidal Expiratory Flow; IC, Inspiratory Capacity; HR, Heart Rate; O2,
Oxygen; D, Change from Rest to min 6.
a P < 0.05 vs. controls.
b P < 0.05 vs. Non-dyspneic COPD group.
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subjects, dyspneic COPD subjects in daily life had the
following findings: (a) lower exercise performance and
higher Borg ratings; b) greater emphysema, lower airway
luminal area, and thigh muscle wasting on CT scan; and c)
increased ventilatory demand, dynamic hyperinflation, and
arterial oxygen desaturation during exercise, which were
related to greater dyspnea perception. These findings
provide support to the inclusion of dyspnea in the new
GOLD classification scheme1 as it clearly separates GOLD
stage 1 COPD subjects with distinct physiologic and
morphologic features as well as exercise outcomes.
Subjects with mild COPD who experienced dyspnea in
daily activities (mMRC 1e2) had a clinically meaningfulreduction in exercise performance and experienced more
dyspnea during walking (at least 94 m less and 2.6 points
more than comparison subjects, respectively). These
differences in distance walked and Borg ratings are higher
than a minimal important difference suggested for these
outcomes (for walking, 54e80 m37; for Borg scale, 1
point38). Our findings confirm prior data observed during
cycling exercise in a similar population14 and extend them
by relating morphologic characteristics of the lung and
thigh muscle on CT scan with these outcomes. While
subjects with the greatest airway lumen narrowing expe-
rienced the greatest dyspnea intensity and the lowest
exercise performance, those with greatest thigh muscle
wasting also walked the least. Additionally, CT measures of
Figure 1 A. Borg dyspnea ratings and B. dyspnea/VE over
time during the six-minute walk are shown. Data are shown as
mean  SEM for dyspneic (-) and non-dyspneic ( ) GOLD 1
COPD subjects and smoker controls (B). yP < 0.05 vs. controls;
*P < 0.05 vs. Non-dyspneic COPD group.
Dyspnea and exercise limitation in mild COPD 575emphysema and airway narrowing may be the structural
basis of expiratory flow limitation and dynamic hyperinfla-
tion we observed in our subjects. We think that these
observations are not explained by poor effort during
walking or age differences across study groups. Standard-
ized encouragement was given to the subjects during the
6MWT. The dyspneic group reached 77% of maximum heart
rate, similar to that observed in normals in a multicenter
study.39 Mean dyspnea ratings and mean walking speed
(1.36  0.21 m/s) were similar to those described in
patients with more advanced disease.40 The comparable
subjects’ walking speed between our and a prior study40
suggests that our subjects likely walked at their maximum
sustainable speed. Additionally, the analyses were adjusted
by age. We identified three potential contributors to
exertional dyspnea and exercise capacity in these subjects:
abnormalities of resting and dynamic ventilatory
mechanics; reduced peripheral muscle mass; and inappro-
priate cardiovascular response.
Our data demonstrate that during walking the ventilatory
demand in dyspneic subjects was increased suggested by
higher V0E/V0CO2 and V0E/V0O2 ratios. Potential explanations
for this finding from our data are larger ven-
tilationeperfusion (V/Q) inequalities (reflected by lowerDLCO/VA). As a result, these patients showed lower PaO2 at
rest along with higher drop in SpO2 at the end of the walking.
Further, we found that subjects with the greatest burden of
emphysema on CT scan had both the lowest DLCO/VA
(r Z 0.50; P < 0.0001) at rest and SpO2 at the end of
walking (r Z 0.25; P Z 0.04) supporting structur-
eefunction relationships for the V/Q imbalance and
pulmonary gas exchange in mild COPD. Our findings confirm
prior observations of V/Q mismatch at rest41 and during
cycling14 in mild COPD. Unlike cycling, in the self-paced
walking the gas exchange abnormalities of the lungs were
enough to cause a modest but significant decline in oxygen
arterial saturation at min 6 among dyspneic subjects. The
increased ventilatory demand likely led to greater dyspnea
and exercise limitation. In this study, significant associations
between dyspnea ratings, V0E/V0CO2, and V0E/V0O2 ratios
were found. Consistent with prior investigation,14 subjects
with the highest ventilatory demand (assessed by V0E as %
MVV) tended to report the greater dyspnea intensity
(r Z 0.23, P Z 0.054). Finally, subjects with the lowest
SpO2, and thus the largest V/Q mismatch and ventilatory
demand, had the greatest Borg ratings at the end of walking.
In this study we also found that dyspneic subjects had
significant ventilatory constraints during walking as they
exhibited a marked expiratory flow limitation during tidal
breathing at end-exercise. It is of note that this ventilatory
limitation manifested despite an apparent preserved
ventilatory reserve as assessed by the end-exercise V0E (%
MVV). This finding is consistent with early observations
among patients with mild-to-moderate COPD.42 During
walking our subjects had to face a decreased IC (as % pre-
dicted) along with an increase in end-expiratory lung
volume (0.26  0.1 L). Additionally, dyspneic subjects had
higher resting ventilatory mechanical loads suggested by
greater airway obstruction and air trapping. Thus, their
steeper dyspnea/V0E slopes were the combined result of
greater resting ventilatory mechanical loads and exercise-
induced hyperinflation. The decline in IC was approxi-
mately a half of that during incremental cycling (0.54 L).14
Two reasons may account for the lower decrease in IC: a)
the short duration of the 6MWT likely does not allow
developing a greater degree of DH; b) the subjects’ walking
speed was probably at their critical level, and consequently
they were exercising at or below the ventilatory threshold.
This is supported by the fact that no dyspneic patients
reached a RER >1.0 and both average DIC and V0E (as %
MVV) were comparable to those observed at the ventilatory
threshold during cycling in a similar population (0.28 L and
51%, respectively).14 In dyspneic subjects the reduction in
IC tended to limit the VT response. Subjects with the lowest
VT (as % VC) expansion had the greatest reduction in IC%
predicted (r Z 0.32, P Z 0.007). Supporting this assump-
tion, the lower VT expansion in dyspneic subjects was likely
due to decreased VT/TI (PZ 0.08 vs. controls), since TI did
not differ significantly from that of comparison subjects.
We have previously found that a reduced mean inspiratory
flow is likely the response to increased inspiratory loads.43
The mechanical restriction we observed largely explained
exertional dyspnea and reduced exercise performance in
our subjects. We found that both IC% predicted and EFL
were the highest correlates of Borg ratings and were
independent predictors of dyspnea in exertion in separate
Figure 2 A. Oxygen consumption (V0O2), B. Carbon dioxide production (V0CO2), C. Ventilatory equivalent for carbon dioxide (V0E/
V0CO2), and D. Oxygen saturation by pulse oximeter (SpO2) responses to the six-minute walk test are depicted. Data are shown as
mean  SEM for dyspneic (-) and non-dyspneic ( ) GOLD 1 COPD subjects and smoker controls (B). yP < 0.05 vs. controls;
*P < 0.05 vs. Non-dyspneic COPD group.
576 A.A. Dı´az et al.multivariate models. Additionally, a greater airflow
obstruction at baseline was also an independent predictor
of increased exertional dyspnea and reduced exercise
performance. The relationship between airflow obstructionFigure 3 End-exercise tidal flow-volume loops (dotted-line) place
smoker control subject (A) with no tidal expiratory flow limitation
with tidal expiratory flow limitation (EFL) over >70% of the VT ar
overlapping the maximal flow-volume curve.and 6MWT was consistent with observations made by Mak
et al.44 Similarly, both IC% predicted and EFL again were
independent determinants of exercise capacity in separate
models.d within their maximal flow-volume curves at rest are shown. A
(no overlap between curves) and a dyspneic-COPD subject (B)
e depicted. EFL is represented by the tidal flow-volume loop
Figure 4 Inspiratory capacity (DIC)% predicted response to
the six-minute walk test is shown. Data are shown as
mean  SEM for dyspneic (-) and non-dyspneic ( ) GOLD 1
COPD subjects and smoker controls (B). yP < 0.05 vs. controls;
*P < 0.05 vs. Non-dyspneic COPD group.
Figure 5 Scatter plot of log Borg dyspnea ratings at min 6 to
Dinspiratory capacity (IC)% predicted from rest is shown. Data
points represent dyspneic (-) and non-dyspneic ( ) GOLD 1
COPD subjects and smoker controls (B).
Dyspnea and exercise limitation in mild COPD 577CT assessment of the lungs demonstrated that subjects
with the narrowest airway lumen measured as Ai and those
with the greatest burden of emphysema on CT scan had the
greatest EFL (as % VT) and decrease in IC% predicted. These
relationships suggest that these CT anatomical changes
reflecting increased airway resistance and elastic recoil loss
(emphysema) may be the morphological basis of expiratory
flow limitation and its mechanical consequence, dynamic
hyperinflation. Also subjects with the greatest airway nar-
rowing on CT scan reported greater dyspnea intensity and
walked the least.
We also observed that those patients with lower RTMCT-
CSA experienced greater dyspnea intensity and lower exer-
cise performance. This morphologic assessment of the thigh
muscle was an independent explanatory factor for distance
walked in regression analysis. Muscle wasting might prone
to leg fatigue. A recent study showed that COPD subjects
who experienced leg fatigue during cycling obtained the
greatest increase in six-minute walking distance afterFigure 6 Scatter plot of six-minute walk distance (6MWT) to A
tomography (RTMCT-CSA), B. DO2 pulse % predicted from rest and C. D
points represent dyspneic (-) and non-dyspneic ( ) GOLD 1 COPDtraining,45 which suggests that thigh muscle wasting might
be amenable to intervention. Based on recent investiga-
tion,17 we speculate that the thigh muscle loss in dyspneic
subjects with mild COPD may result from avoiding daily
symptom-limited exercising. Further replication in a larger
cohort of subjects with mild COPD undergoing direct
assessment of muscle strength is warranted.
An unexpected finding in this study was that dyspneic
subjects had an attenuated increase in oxygen pulse than
either non-dyspneic COPD or control subjects and that DO2
pulse was an independent determinant of distance walked.
Recent studies have confirmed an association between the
degree of lung hyperinflation and a reduction in O2 pulse,
a crude non-invasive measure of stroke volume during
exercise, in subjects with moderate-to-severe COPD.46e48
Consistent with these studies, our results indicate a signifi-
cant association between concurrent IC% predicted and O2
pulse at end-exercise (r Z 0.32, P Z 0.007). It should be
noted, however, that the reduced O2 pulse could merely
reflect the lower V0O2 achieved by the dyspneic patients.
Further studies with direct assessment of the cardiac. cross sectional area of the right thigh muscle by computed
inspiratory capacity (IC)% predicted from rest are shown. Data
subjects and smoker controls (B).
578 A.A. Dı´az et al.function may reveal the potential contribution of cardiac
dysfunction to exercise capacity in mild COPD.
Several limitations should be noted. Our subjects were
recruited from clinics and may not be representative of the
whole population with mild COPD. Thus, caution should be
exercised to generalize these findings. We did not assess the
psychological profile of our subjects, which may explain
differences in dyspnea perception among study groups. We
did not directly measure cardiac function and used a non-
invasive measure of stroke volume, O2 pulse. Thus, the
potential role of cardiac dysfunction due to hyperinflation on
exercise impairment is rather a hypothesis-generating
finding. We did not include a muscle strength assessment
and relied on an objective measure of CT thigh muscle cross-
sectional area (CSA). Thus, the potential mechanism linking
the thigh muscle wasting and exertional dyspnea remain to
bedetermined.Other radiation-free imagingmodalities such
as MRI49 and ultrasound50 have emerged to assess CSA of
peripheral muscles. However, the former technique is
expensive andnotwidely available and the latter is operator-
dependent and requires training.
This study in subjects with mild COPD (GOLD stage 1)
shows that those with dyspnea in daily life had reduced
exercise capacity and exertional dyspnea along with distinct
morphologic features including greater emphysema, airway
lumen narrowing, and peripheral muscle wasting on CTscan.
They also had increased ventilatory demands, dynamic
hyperinflation, and arterial oxygen desaturation during
exercise, which were linked to dyspnea in exertion as well as
to emphysema and airway narrowing. These differences in
exercise outcomes as well as in morphologic and physiologic
features of the lung and thigh muscle between GOLD 1 COPD
subjects with and without dyspnea in daily life provide
support to include the assessment of breathlessness in the
new GOLD classification scheme for this disease.1
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